Biofrontera Inc. (BFRI)
NASDAQ: BFRI · Real-Time Price · USD
0.8123
-0.0006 (-0.07%)
Dec 12, 2025, 4:00 PM EST - Market closed
Biofrontera Market Cap
Biofrontera has a market cap or net worth of $9.46 million as of December 12, 2025. Its market cap has increased by 19.71% in one year.
Market Cap
9.46M
Enterprise Value
10.94M
1-Year Change
19.71%
Ranking
Category
Stock Price
$0.81
Market Cap Chart
Since the IPO on October 29, 2021, Biofrontera's market cap has decreased from $35.28M to $9.46M, a decrease of -73.18%. That is a compound annual growth rate of -27.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 9.46M | 12.02% |
| Dec 31, 2024 | 8.45M | 100.93% |
| Dec 29, 2023 | 4.20M | -82.82% |
| Dec 30, 2022 | 24.47M | -80.97% |
| Dec 31, 2021 | 128.63M | 264.59% |
| Oct 29, 2021 | 35.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |